Alcol excess intake and excess water retentity in the bladder -what to do?
Answers
Vommit.............
Answer:
Explanation:
THE ability of chlorpropamide to reduce urinary
volume in patients with neurogenic diabetes insipidus
has been recently described by Arduino, Ferraz &
Rodriguez (1966), Meinders, Touber & De Vries
(1967), Reforzo-Membrives et al. (1968), Hocken &
Longson (1968), and Andreani, Cinotti & Stirati
(1969).
This therapy is potentially of great importance in
the treatment of neurogenic diabetes insipidus;
therapy with chlorpropamide, however, is not always
without complications both in the short or longterm management of these patients. Initially there were no reports that patients with
diabetes insipidus undergoing therapy with chlorpropamide were prone to hypoglycaemic episodes
(Meinders, Touber & De Vries, 1967; ReforzoMembrives et al., 1968), but with increasing use of
this type of therapy it soon became apparent that
hypoglycaemia was the most frequent and important
complication.
We have observed symptomatic hypoglycaemia
in the early phases of treatment, but with continued
treatment it becomes less frequent (Cinotti et al.,
1969).
In this paper we emphasize that these patients,
when treated with chlorpropamide, may be also
subject to water retention and may present the
clinical symptoms of water intoxication.
Observations on a patient with idiopathic neurogenic diabetes insipidus (INDI) who developed
water retention and mild symptomatic hyponatraemia during long-term treatment with chlorpropamide are reported. This case may also raise some
intriguing questions concerning the mechanism of
action of chlorpropamide and the physiopathology
of diabetes insipidus.